Live Price
Live Volume
Chart Volume 0
Volume 0
5 secCandel Therapeutics Market Segments
Premarket
+0.06(+0.53%)
| Open | $11.24 |
|---|---|
| Close | $11.30 |
| Low | $11.19 |
| Low Change | -0.05 (-0.47%) |
| High | $11.35 |
| High Change | +0.11 (+0.98%) |
| Range | $0.16 |
| Volume | 32.273K |
| Dollar Volume | $364.68K |
Overnight
*No Trades in Segment
After Hours Yesterday
+0.04(+0.35%)
| Open | $11.33 |
|---|---|
| Close | $11.37 |
| Low | $11.15 |
| Low Change | -0.18 (-1.59%) |
| High | $11.46 |
| High Change | +0.13 (+1.15%) |
| Range | $0.31 |
| Volume | 253.68K |
| Dollar Volume | $2.88M |
Regular Trading Hours Yesterday
-0.72(-5.98%)
| Open | $12.05 |
|---|---|
| Close | $11.33 |
| Low | $11.20 |
| Low Change | -0.85 (-7.05%) |
| High | $12.05 |
| High Change | +0.00 (+0.00%) |
| Range | $0.85 |
| Volume | 1.687M |
| Dollar Volume | $19.11M |
Premarket Yesterday
-0.45(-3.66%)
| Open | $12.30 |
|---|---|
| Close | $11.85 |
| Low | $11.85 |
| Low Change | -0.45 (-3.66%) |
| High | $12.30 |
| High Change | +0.00 (+0.00%) |
| Range | $0.45 |
| Volume | 1.717K |
| Dollar Volume | $20.35K |
Candel Therapeutics News
3 months agoinvesting.comCandel Therapeutics stock falls despite phase 3 trial publication
4 months agobenzinga.comCandel Therapeutics Reports Positive Phase 3 Prostate Cancer Trial Data
7 months agoinvesting.comCandel Therapeutics stock falls on $100 million offering pricing
7 months agobenzinga.comStock Market Today: Dow Jones, S&P 500 Futures Rise Ahead Of Q4 GDP Numbers—Grail, Candel Therapeutics, Copart In Focus
Candel Therapeutics Top Trades
Candel Therapeutics's top trade so far today returned +1.01%, while the top short trade returned -0.47%.
Candel Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $12.37 |
|---|---|
| 10 Day Moving Average (SMA10) | $12.77 |
| 20 Day Moving Average (SMA20) | $12.71 |
| 50 Day Moving Average (SMA50) | $11.08 |
| 100 Day Moving Average (SMA100) | $9.61 |
| 200 Day Moving Average (SMA200) | $7.50 |
Candel Therapeutics Statistics
| Average Volume (30 Days) | 1.16M |
|---|---|
| P/E Ratio (Current) | -10.49 |
| EPS (Current) | -$1.16 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$57.32M |
| Cash Ratio | 15.89 |
| Current Ratio | 16.09 |
| Quick Ratio | 16.09 |
| Debt to Equity | 0.38 |
| Enterprise Value | $777.50M |
| EV to EBITDA | -10.90 |
| EV to Sales | — |
| Price to Book | 7.38 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.43% |
| Return on Equity | -0.70% |
Candel Therapeutics Stock Splits
There have been no stock splits for Candel Therapeutics (CADL).
Candel Therapeutics Dividends
There have been no dividends for Candel Therapeutics (CADL).